Executive Summary: The United Kingdom appears to have greater utilization of Durable Medical Equipment (DME) products as compared to the US Medicare Population (over half of the UK vs 21 percent of the US Medicare population). However, this variation in utilization may be driven by definitions rather than patient need. The definition of DME varies … Continue reading
Executive Summary: On January 8th, 2024 the Senate Committee on Health, Education, Labor, and Pensions (HELP) sent letters to the CEOs of the four largest manufacturers of inhalers sold in the United States (AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline (GSK), and Teva) launching an investigation into the high price of inhalers used for Asthma and Chronic Obstructive … Continue reading
Executive Summary: The Biden administration has encouraged states to use Medicaid funds to alleviate the homelessness crisis with around 20 states directing billions of dollars from their Medicaid program to provide short-term housing for those experiencing homelessness, with some states devoting anywhere from six to fifteen percent of its Medicaid spending to such programs. In … Continue reading
It is common knowledge that the United States spends substantially more money on health care than other developed nations, yet it is by no means the healthiest country. Health care accounts for one-sixth of United States’ gross domestic product (GDP), but morbidity continues to rise. Two out of three American adults are obese, one-third of American adults have high blood pressure, and diabetes prevalence is … Continue reading
Overview Late June, legislation that would transform California’s health care system to a single-payer system was brought to a halt by Assembly Speaker Anthony Rendon, despite approval in the state Senate and loud public support. Single-payer health insurance eliminates the numerous private and government health insurers and replaces them with a single public organization that … Continue reading
Experts across the political spectrum have questioned how much society should be willing to pay for new and expensive treatments, especially if another treatment exists with a proven track record. Although it often escapes policymakers, the heart of this debate should be medical efficacy. For both the new treatment and the old, do they work? How … Continue reading
“I looked at that menu, and I just couldn’t control myself!” How many times have you walked into a restaurant planning to order a salad but instead got a whopping 2,000 calorie steak meal? We’ve all faced shortages of self-control, trading in short-term gain for long-term strain. Choosing the inferior food option is only one … Continue reading
The graying of America is not a new fear for economists and politicians. Before even the earliest Baby Boomers began retiring, economists were making predictions about the hardships America would undoubtedly face as it aged. Many say those problems have already begun, while others argue they have been over exaggerated and prematurely predicted. The American … Continue reading
Slowing the biological aging process (senescence) is now a realistic goal. According to a new research study published in Health Affairs, the elimination of diseases such as cancer and heart disease would have less effect on longevity and quality of life than delaying aging itself. Although most medical research remains focused on combating individual diseases, … Continue reading
The recent debates on retirement policy are anything but productive. The main points revolve around the rising debt and health care costs, as well as increasing the retirement age. While these concerns are important, retirement policy in the United States (and in the world) needs another look. More and more people are living to the … Continue reading
You must be logged in to post a comment.